[1] 张云萍.短期持续胰岛素输注治疗对初诊2型糖尿病患者胰岛β细胞功能的影响[J].糖尿病新世界,2014,34(10):18-20. [2] Kaneto H,Matsuoka TA.Down-regulation of pancreatic transcription factors and incretin receptors in type 2 diabetes[J].World J Diabetes,2013,4(6):263-269. [3] 段素静,谌剑飞,谭薇.短期持续胰岛素输注治疗酮症起病的2型糖尿病疗效观察[J].中西医结合心脑血管病杂志,2013,11(3):363-364. [4] 方丽萍.短期持续胰岛素输注治疗对初诊2型糖尿病患者胰岛β细胞功能的影响[J].中国现代医生,2013,51(12):48-50. [5] 张剑.两种胰岛素强化治疗对初诊2型糖尿病患者胰岛β细胞功能的影响[J].北方药学,2015(7):121- 122. [6] Pietropaolo M,Barinas-Mitchell E,Kuller LH.The heterogeneity of diabetes: unraveling a dispute: is systemic inflammation related to islet autoimmunity [J] ?Diabetes,2007,56(5):1189-1197. [7] Zatalia SR,Sanusi H.The role of antioxidants in the pathophysiology,complications,and management of diabetes mellitus[J].Acta Med Indones,2013,45(2):141-147. [8] 胡龙江,吕湛,苟连平.胰岛素抵抗、瘦素抵抗与2型糖尿病并发冠心病的关系研究[J].中华临床医师杂志(电子版),2011,5(2):387-391. [9] Deetman PE,Bakker SJ,Dullaart RP.High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome[J].Cardiovasc Diabetol,2013,12:166. [10] Morteza A.The lost correlation between leptin and CRP in type 2 diabetes[J].Eur Cytokine Netw,2013,24(1):53-59.
2018, Vol. 35 
